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Among the various health problems associated with obesity, cardiac autonomic neuropathy is 
one of the serious and relatively under-investigated problems. The authors have previously 
showed, in 2008, that vagal dysfunction is the main underlying factor in cardiac autonomic 
neuropathy in a rat model of congenital obesity. The aim of this article is to review the 
published findings in this topic since then and to compare the data in rats with those in human 
subjects. 
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INTRODUCTION   
Obesity has emerged world-wide as a major public 
health concern, and Africa is not an exception. It has 
been estimated that obesity/overweight is increasing by 
an average of 5% annually in sub-Saharan countries 
(Ziraba et al., 2009). Epidemiological and experimental 
studies show that obesity is a causative factor in the 
development of cardiovascular disease.  In this case, 
the deleterious effects of obesity upon autonomic 
function are seen, at least in part, as a probable 
contributor to ultimate cardiovascular dysfunction.  
Many of the earlier studies that outlined the 
relationship(s) between obesity and circulatory 
dysfunction were conducted using animals, especially 
rats or mice fed calorie rich diets or strains genetically 
biased to become obese.  The results of many of these 
rodent experiments have only subsequently been 
followed up with corollary observations in man.  
Recent human studies reported strong association of 
waist-hip ratio and low heart rate variability in humans 
(Yadav et al., 2017). Eleven years ago (2008) our study 
in Zuckerfa/fa obese rats vs. a control strain was among 
the earlier observations of diminished 
 
Parasympathetically-mediated bradycardia during an 
acute behavioral challenge (i.e., classical aversive 
conditioning) (El-Wazir, et al., 2008).  In the sense of 
‘translational science’ this earlier study is primarily of 
interest to the degree that the findings are applicable to 
human obesity.  The purpose of the present account is 
to summarize our earlier work and then to examine the 
subsequent decade’s findings in human studies that are 
either congruent or inconsistent with our earlier rat 
findings.  As such, it should provide objective 
validation or refutation of an important aspect – 
autonomic control - of the use of rats to model human 
obesity. 
 
Review of our obese rat cardiovascular ‘stress 
response’ and its autonomic control  
The Zucker obese rats used in our study (El-Wazir et 
al., 2008) were 9- to 11-weeks of age. The obese 
animals (n=10) weighed 452 +45 g (mean + SD) while 
the age-matched control rats (n=13) weighed 280 + 46 
g.  We found no significant differences in mean arterial 
blood pressure (mBPa via indwelling femoral artery 
catheter) while the rats were unanesthetized and at rest 
between obese (111.7 + 5.6 mm Hg) vs. lean (113.1 + 
7.0 mm Hg).  Likewise, resting heart rate (HR) was 
similar in obese (422 + 22 /min) and lean (413 + 43 
/min.).  The major novel finding of the study was that 
the bradycardia observed in a fully trained rat during a 
‘stressful stimulus’ (a 15 sec. ‘conditional stimulus’ 
(CS) tone followed by 0.5 sec. tail shock) was 
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significantly (p < 0.05) smaller in the obese (-17.8 
+21.7 /min) as compared to the lean group (-46.0 + 
21.5 /min).  Fig.1 is a composite analysis (i.e., each 
recording is an ensemble average across the lean 
(black) and obese (red) animals).  Note particularly the 
significantly smaller bradycardia during the CS-
induced stress in the obese (red) animals (i.e., vs. pre-
tone control) (p < 0.05).  This HR conditional response 
was essentially eliminated following delivery of 
atropine (not shown, Fig.1); thus, the HR slowing may 
be attributed largely to increased cardiac 
parasympathetic activity.  The conditioned increase in 
mBPa (not shown, Fig.1) was not significantly different 
between groups.  Finally, the reflex change in HR 
divided by the change in mBPa () HR/mBPa) produced 
by a bolus iv infusion of phenylephrine, an index of 
baroreceptor function, was significantly smaller in 
obese (n=6; -1.36 + 0.60) vs. lean (n=5; -2.80 + 0.92).  
Conversely, the reflex tachycardia following iv 
nitroprusside did not differ between groups.   
Our prior work (e.g., Randall 1994) with the 
conditioning paradigm helps interpret these findings.  
First, the pattern of changes in SNA relative to pre-tone 
control consists of an initial ‘sudden burst’ followed 
immediately by a momentary decrease which is next 
replaced during the majority of the CS by a modest 
increase over control.  This patterned, learned 
cardiovascular response ‘evolves’ as the animal 
acquires the association between the tone and shock 
(El-Wazir, 2005).  Second, the accompanying increases 
in mBPa are reliably predicted by these changes in SNA 
(Burgess 1997).  If so, our finding that the changes in 
blood pressure during the CS are similar in the two 
groups of rats implies that the underlying changes in 
SNA must be similar between the two groups.  Finally, 
though we have not recorded changes in 
parasympathetic activity, the bradycardia shown in 
Figure 1 apparently results from baroreflex activity 
secondary to the conditional increase in BP (Randall, et 
al., 1994). 
 
Age-matching of rats and humans 
Our present intention is to compare these findings with 
the closest possible match to subsequent human studies.  
Perhaps the first issue, therefore, concerns the 
equivalent human developmental age as compared to 9-
11-week old rats: how many rat days are equivalent to 
one human year?  A recent review (Andreollo, et al., 
2012) of the relevant literature matching rat 
development to human development explains that rats 
become sexually mature at 6 weeks while humans don’t 
experience puberty until between about 12 to 13 years.  
The ‘non-linear’ differences in rate of-maturity 
between the two makes comparison difficult, but over 
the total lifespan Andreollo and colleagues (2012) 
suggest that during the ‘adult phase’ 11.8 rat days is 
equivalent to 1 human year, while across the entire life-
span 13.8 rat days is equivalent to one human year.  
Using Andreollo’s equivalents and accepting 6 weeks / 
12 years as sexual maturity in rat / human, we estimate 
that our animals were roughly equivalent to humans of 
23-24 years of age.  Given the relative paucity of 
published human studies we have accepted a somewhat 
wider human age range for consideration in our 
comparisons. 
 
Assessments of autonomic function in humans 
Autonomic function in humans is often evaluated using 
heart rate variability (HRV) as assessed either in the 
time or frequency domain.  Moreover, as in our rat 
study, the physiological response to a challenge can be 
particularly telling in human tests; challenges to 
homeostasis have often included standing-up from 
supine or lying down (e.g., Makary et al., 1999).  
Parasympathetic influences on heart rate are often 
evaluated in terms of ‘high frequency power’ (i.e., 
power in the HR ‘signal’ as revealed by Fourier 
analysis within the frequency range typically, in the 
human, between 0.15 to 0.40 Hz.)  We agree, in fact, 
since in resting dog – an animal with significant cardiac 
parasympathetic activity while at rest – selective 
surgical interruption of the parasympathetic fibers 
projecting to the SA-node essentially eliminates the 
high frequency peak (Randall 1991).  The low 
frequency peak (human:  0.04 to 0.15 Hz) is often taken 
as an approximate index of cardiac sympathetic 
nervous activity (SNA).  In dog, selective SA-nodal 
parasympathectomy significantly decreases this power, 
but does not eliminate it; addition of -adrenergic 
blockade (i.e., administration of propranolol) further, 
and significantly, decreases this power in the low-
frequency range of HRV (Randall 1991).  Direct 
recording of muscle sympathetic nerve activity has also 
been reported in lean vs. overweight or obese humans 
(Lambert et al., 2010).   
 
Identification of comparable studies of ‘young humans’ 
conducted during the ensuing decade 
We identified 5 studies of autonomic function in human 
obese vs. lean subjects generally within the prescribed 
age range that were published over the 10 years since 
our 2008 paper.  The average age and weight of Rossi, 
et al.’s (2015) obese individuals (24 men / 20 women) 
were 20.45 + 1.57 years and 102.3 + 20.82 kg, 
respectively, while their ‘eutrophic’ (24 men/ 24 
women) averaged 20.7 + 1.39 and 62.89 + 10.47 kg.   
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Fig. 1. The rats were un-disturbed while in a comfortable restraining ‘sock’ for first 9 seconds (i.e., pre-tone control, left 
portion of time base); the 15 sec. long tone was presented during the dark bar on the X-axis, and the short shock was presented 
at the end of the dark bar; the irregular fluctuations in the recordings during shock delivery are unreliable because of the rats’ 
flinching during the shock.  The heart rate slowing during the stressful stimulus (i.e., 15 sec. tone) was significantly smaller in 
the obese group vs. the lean animals.  
 
 
Lee, et al. (2014), who included an orthostatic 
challenge (lower body negative pressure, LBNP) in 
their work, studied obese individuals who were 27.5 + 
9.3 years of age and 100.8 + 14.9 Kg. while their non-
obese individuals were aged 26.0 + 7.3 yrs and 66.3 + 
11.9 kg.  Muralikrishnan, et al. (2013) studied 31 obese 
people (25.42 + 7.86 yrs; BMI = 26.84 + 2.47 kg/m2 
(weight was not provided)) and 31 ‘normal’ (25.38 + 
4.61 years and 21.71 + 2.99 kg/m2). Park, et al. (2012) 
reported recordings of muscle sympathetic nerve 
activity (mSNA) responses to the challenge of the cold 
pressor test (CPT) and static hand grip (SHG) in 12 
overweight subjects (32.3 + 2.2 yrs; 182.7 + 7.0 lbs) 
and in 12 lean individuals (28.9 + 1.4 yrs (SEM); 138.4 
+ 5.0 lbs); although these individuals were older than 
our estimated rat-human comparison, because the study 
recorded mSNA and also included a sympatho-
excitatory challenge renders it of particular interest.  In 
addition, Indumathy, et al. (2015) examined response 
to standing, deep breathing and isometric handgrip in 
their obese (29.84 + 5.88 year; 68.06 + 7.66 kg) group 
and their 28.33 + 7.22 year old controls (54.44 + 6.40 
kg). 
Comparisons of effects of obesity on autonomic 
function in age-matched humans and Zucker rats 
We observed no between-group differences in our rats’ 
mBPa during the pre-tone control.  Likewise, Park, et 
al. (2012), Lee, et al. (2014) and Muralikrishnan, et al. 
(2013) report similar control mBPa across their groups, 
while Indumathy, et al. (2015) and Rossi, et al. (2015) 
reported higher arterial pressure in their obese 
individuals compared to controls.  We also reported no 
difference in pre-tone HR; while Park, et al’s findings 
in this regard agree with ours, the overweight or obese 
subjects for the other studies (Lee, Rossi, Indumathy, 
Muralikrishnan) had elevated resting HR.  HR, in our 
experience, is quite responsive to the subject’s status, 
emotional and otherwise; we adapted our rats to the 
sock restraint such that, we believe, their HR was close 
to ‘resting’.  In any case, it would be difficult on the 
basis of control HR alone to draw any firm conclusions 
on any effects of obesity on autonomic balance. 
The HR power spectra from the obese individuals 
studied by Rossi, et al. (2015), as well as Indumathy, et 
al. (2015) had significantly lower HF power than 
observed in their lean, or control, subjects; such 
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findings would typically be interpreted to have resulted 
from decreased parasympathetic control of HR. 
Absolute LF power in Rossi’s study did not differ 
between groups, but normalized LF power was higher 
in the obese; Indumathy (2015) reported both a higher 
total and normalized LF value in his obese subjects.  
The LF/HF ratio, often regarded as an index of the 
relative balance of sympathetic and parasympathetic 
tone, was significantly higher in the obese as compared 
to the ‘eutropic’ people in both studies.  These 
investigators conclude that, at rest, obesity was 
associated with a reduction in parasympathetic and a 
relative predominance of sympathetic activity.  
Muralikrishnan, et al. (2013) used Poincare Plot 
analysis to come to the same conclusion.  Finally, Park, 
et al. (2012) recorded mSNA via microneurography; 
baseline bursts/min. in the lean (20.5 + 2.2) tended 
toward fewer per minute than observed in the 
overweight (27.8 /min.), but the difference fell short of 
statistical significance (p = 0.08). 
The study referenced immediately above by Park, et al. 
(2012), is particularly reminiscent of our overall rat 
work (Randall, et al., 1994) in that they examined 
changes in mSNA during sympathoexcitatory 
challenges: the cold pressor test (CPT) and static 
handgrip exercise at 30% of maximum (SHG 30%).  
They reported no significant between group differences 
in the increases (vs. rest) in mBPa or in HR during the 
moderate hand grip, though systolic pressure increase 
in the overweight subjects (+16.6 + 1.6 mm Hg) tended 
(p = 0.17) to be blunted compared to the lean (+22.4 + 
3.5 mm Hg); there was no difference in the magnitude 
of the increase in mSNA in the overweight (+13.0 + 1.6 
/min) as compared to the lean (+11.9 + 1.3 /min.).  
Recall that we (El-Wazir et al., 2008) saw no difference 
(i.e., obese vs. lean rats) in the change in mBPa during 
the stress tone which, because changes in arterial 
pressure ‘map’ (i.e., are closely related to) changes in 
SNA (Burgess, 1997), implies that underlying changes 
in SNA were similar. Conversely, while the changes in 
pressure and HR were similar between groups during 
the cold pressor test, the overweight individuals 
increased mSNA bursts/min more (+18.1 + 2.8 /min) 
than the lean (+10.8 + 1.2 /min; p = 0.03). 
The major focus of Indumathy, et al’s (2015) study was 
to investigate the relationship of their indices of 
sympathovagal imbalance (SVI) to anthropometric 
indices (e.g., waist or hip circumference), but they also 
reported comparisons of the “30:15 ratio (ratio of 
maximum RR interval at 30th beat to minimum RR 
interval at 15th beat following standing,” i.e., orthostatic 
challenge) and determined the arterial pressure at the 
first minute and 2nd minute of contraction () DBPIHG or 
maximum rise in diastolic blood pressure above 
baseline) during an isometric handgrip test at 30% of 
maximum voluntary contraction.  On the bases of these 
“classical autonomic function tests” in the obese vs. 
control group they reported decreased vagal reactivity 
in their obese subjects during the orthostatic challenge 
and, during the SHG, they found increased sympathetic 
reactivity in the obese subjects.  As a result of these 
findings they conclude that differences between the 
spectral LF:HF ratio in the control (0.69 + 0.39; n=43) 
and obese group (1.41 +0.73; n=45, p < 0.001) are 
attributable to “concomitant increase in sympathetic 
activity and reactivity as well as to the decrease in 
parasympathetic activity and reactivity” (quoted from 
p. 62).  Lee, et al. (2014) also reported reduced 
orthostatic tolerance in obese humans which, on the 
basis of previously established alterations in autonomic 
function in humans, “support the contention that 
autonomic nervous system activity is altered with 
weight gain and obesity,” but they do not offer a more 
specific analysis. 
The subjects in the study by Yadav, et al. (2017) were 
somewhat older (average: 30 – 32 years), and the age 
range (18 – 75 years) within the normal weight and 
within the obese individuals was large.  Irrespective, 
we note parenthetically that they report significantly 
lower HRV HF power in the obese (216 ms2) as 
compared to the normal weight (640.5 ms2; p = 0.014); 
LF power was lower (obese: 248 ms2; normal weight: 
480 ms2; p = 0.063) while LF/HF was higher (obese: 
1.2; normal weight: 0.79; p = 0.045).  In short, they 
state that variables which reflect the cardiac 
parasympathetic nerve activity were lower in obese 
persons than in normal weight persons while the 
sympathetic marker LF/HF ratio was increased in obese 
subjects. It may be noteworthy to state that this study 
was conducted on Asian subjects (Nepal), which may 
highlight the trans-ethnicity of the obesity-associated 
cardiac autonomic dysfunction.  
 
Baroreflex function in lean vs. obese individuals 
None of the five studies we identified assessed 
baroreflex function directly in obese vs. lean subjects, 
so we looked at studies with subjects beyond the 
optimal age-range and/or published other than within 
the most recent decade.  Using a sequence technique 
(Randall & Brown, 2014), Skrapari, et al. (2007) 
compared baroreflex sensitivity in obese (BME > 30 
kg/m2) vs. lean (BMI < 25 kg/m2) women; though aged 
(42 yrs) somewhat older than our range, the data are 
worth our noticing.   They found a severe reduction in 
baroreflex sensitivity by the sequence technique in 
obese (9.18 + 3.77 ms/mm Hg), but otherwise healthy, 
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subjects as opposed to their lean women (19.63 + 9.16 
ms/mm Hg, p < 0.001).  These differences were closely 
associated with the high frequency component (i.e., 
parasympathetic component) of HRV.  Jaju, et al. 
(2016) compared spectral HRV assessments for mental 
(word conflict test; WCT) and physical (cold pressor 
test) challenges for large (n=1149) groups of lean 
(average age:  32.8 yrs; 56.6 kg), overweight (38.0 
years; 68.5 kg) and obese (38.1 yrs; 83.4 kg) 
individuals from 5 large families from an interior 
province of Oman.  Although the average age ranges 
are near our range, the direct applicability of their 
findings to ours is limited because of the wide range of 
the ages of their subjects within any category.  
Nonetheless, we note that they report no differences in 
the HR or mBPa changes (vs. baseline) during WCT or 
CPT in their autonomic parameters or in their index of 
baroreflex function. 
 
Interpretations of comparative rat vs. human findings 
Stables, et al (2013) point out that “it is crucial to be 
able to determine in what ways the animal models are 
similar to the human disease, and in what ways they are 
different” (quoted from p. 75) in their consideration of 
the applicability of animal (primarily rat) models of 
diabetes vs. human diabetic cardiac autonomic 
neuropathy.  We attempt such a comparison here of 
human and rodent (i.e., rat) obesity, where, in our case, 
the rodent obesity is attributable to a genetically 
controlled lack of the leptin receptor in the Zuckerfa/fa 
rat: this animal harbors a missense mutation in the 
leptin receptor gene.  Stables, et al (2013) point out that 
such comparison requires a combination of several 
suggestive tests.  In our rat study the primary novel 
finding depended upon use of a classical aversive 
conditioning paradigm which is sympatho-excitatory 
with, thereby, an increase in mBPa that, in turn, slows 
HR via activation of the baroreflex with resultant 
elevated cardiac PNS activity.  It is difficult, perhaps 
impractical, to identify a corresponding human 
paradigm, which thereby limits our ability to compare 
strictly our animal with human work.  Not 
unexpectedly, multiple inferences are required. 
The human studies are nearly unanimous in positing an 
overall diminution of parasympathetic nervous activity 
in obesity, at least as inferred by HRV or other indirect 
assessments.  It is more difficult to convincingly 
compare findings in these human studies to our major 
conclusion – decreased parasympathetically mediated 
bradycardia in the obese rats attributable to differences 
in baroreflex function – but the findings of Indumathy, 
et al’s (2015)“classical autonomic function tests” 
certainly come close to such a confirmation.  Findings 
are less unanimous as regards differences in 
sympathetic nervous activity. This is, at least in part, 
attributable to the weaker linking of changes in LF 
power (i.e., both sympathetic and parasympathetic 
activity contribute to LF power) and ambiguity in the 
LF/HF ratio (i.e., both increases in LF power, or 
decreases in HF power might contribute to an increased 
ratio) in assessing ‘sympathovagal imbalance’ (SVI).  
Moreover, our conclusions in this regard are inferential 
as based upon our prior assessment of the relationship 
between the coupling of changes in SNA and changes 
in arterial pressure.  Nonetheless, our rat findings are 
generally consistent with a relatively unchanged, or 
only modest increase in sympathetic arousal with acute 
challenge (e.g., orthostatic challenge).  In sum, it 
appears from our perusal of the relevant literature that 
our specific conclusion – diminution of 
parasympathetic autonomic control of HR early in the 
development of obesity with only modest, if any, 
changes in sympathetic activation – is a faithful 
reflection of the human situation. 
What of the underlying mechanism(s) of the lessened 
bradycardia during stress?  Since the bradycardia we 
observed occurs during an elevation in SNA  we 
believe the HR slowing is secondary to baroreflex 
activation induced by the arterial pressure increase 
during the stress.  Since the magnitude of the stress-
induced pressor response was similar in the obese vs. 
lean rats, the input to the baroreceptors should have 
been similar and, at least inferentially, the reflex 
response of the baroreflex was, therefore, similar.  If so, 
the reduced HR slowing is attributable to diminished 
parasympathetic control of the SA-node (i.e., rather 
than diminished sympathetic control).  Our finding that 
the reflex HR slowing to phenylephrine, but not the 
reflex HR acceleration to nitroprusside, was attenuated 
is consistent with this interpretation.  In sum, our 
retrospective examination of the age-appropriate human 
literature published during the last decade indicates that 
our findings in Zucker rat were in an important and 
significant sense ‘translational’ with respect to 




Andreollo NA, dos Santos EF, Arajo MR, Lopes LR.  
Rat’s age versus human’s age: what is the 
relationship?  Arq Bras Cir Dig 25: 49-51, 2012. 
Burgess DE, Hundley JC, Li S, Randall DC, Brown 
DR.  Multifiber renal sympathetic nerve activity 
recordings predict mean arterial blood pressure in 
unanesthetized rat.  Am. J. Physiol., 273 (Regulatory 
Integrative Comp. Physiol. 36): R851 - R857, 1997. 
5
Obesity and autonomic regulation of cardiovascular function 
 
     J. Afr. Ass. Physiol. Sci. 7 (1): 2019        Randall and El-Wazir 
 
 
El-Wazir YM, Li SG, Williams DT, Sprinkle AG, 
Brown DR and Randall DC.  Differential Acquisition 
of Specific Components of a Classically Conditioned 
Arterial Blood Pressure Response in Rat.  Am. J. 
Physiol. Regul. Integr. Comp. Physiol., 289: R784 - 
R788, 2005. 
El-Wazir YM, Li S-G, Smith R, Silcox DL, Brown DR 
Randall DC.  Parasympathetic response to acute 
stress is attenuated I young Zucker obese rats.  Auton 
Neurosci: Basic Clin 143: 33-39, 2008. 
Indumathy J, Pal GK, Pal P, Ananthanarayanan PH, 
Parija SC, Balachander J, Dutta TK.  Association of 
sympathovagal imbalance with obesity indices, and 
abnormal metabolic biomarkers and cardiovascular 
parameters.  Obes Res Clin Prac 9: 55-66, 2015. 
Jaju D, Al Abri M, Hassan MO, Alvarenga JL, 
Comuzzie A, Albarwani S, Al Yahysee S, Bayoumi 
R, Al Hashmi K.  Hemodynamic and autonomic 
reasctivity to mental and physical stress in lean, 
overweight and obese subjects. J Obes Overweight 
2(1), 2016 (doi: 10.15744/2455-7633.2.105) 
Lambert Elisabeth, Sari Carolina Ika, Dawood 
Tye, Nguyen Julie, McGrane Mariee, Eikelis 
Nina, Chopra Reena, Wong Chiew, 
Chatzivlastou Kanella, Head Geoff, Straznicky 
Nora, Esler Murray, Schlaich Markus, Lambert 
Gavin, 2010. Sympathetic Nervous System 
Activity Is Associated With Obesity-Induced 
Subclinical Organ Damage in Young Adults. 
Hypertension 56, 351–358. 
https://doi.org/10.1161/HYPERTENSIONAHA.
110.155663 
Lee JF, Harrison ML, Christmas KM, Kim K, Hurr C, 
Brothers RM.  Elevated resting heart rate and 
reduced orthostatic tolerance in obese humans. Clin 
Auton Res 24: 39-46, 2014. 
Makary SM, Selim HA, El-Wazir YMN, Mahmoud A 
E-A. Physiological assessment of cardiac autonomic 
reflexes in diabetes.  Suez Canal Univ Med J 2: 61-
72, 1999. 
Muralikrishnan K, Balasubramanian K, Ali SMJ, Rao 
BV.  Poincare plot of heart rate variability: an 
approach towards explaining the cardiovascular 
autonomic function in obesity. Indian J Physiol 
Pharmacol 57: 31-37, 2013.  
Park J, Middlekauff HR, Campese VM.  Abnormal 
sympathetic reactivity to the cold pressor test in 
overweight humans.  Am J Hypertension 25: 1236-
1241, 2012 (https: //doi.org/10.1038/ajh. 2012.115). 
Randall DC, Brown DR, Raisch RM, Randall WC.  
SA-nodal parasympathectomy delineates autonomic 
contributions to heart rate power spectrum.  Am. J. 
Physiol. 260 (Heart Circ. Physiol. 29): H985-H988, 
1991. 
Randall, DC and Brown DR.  Closed and open loop 
mechanisms controlling arterial blood pressure in 
waking state in human and experimental animal. 
Bulletin of the Egyptian Society of Physiol Sci 34(1): 
1-6, 2014. 
Rossi RC, Vanderlei LCM, Gonalves ACCR, 
Vanderlei FM, Bernardo AFB, Yamada KMH, da 
Silva NT, de Abreu LC.  Impact of obesity on 
autonomic modulation, heart rate and blood pressure 
in obese young people. Auton Neurosci: Basic Clin 
193: 138-141, 2015. 
Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, 
Papazafiropoulou A, Katsilambros N.  Baroreflex 
sensitivity in obesity: relationship with cardiac 
autonomic nervous system activity.  Obes 15: 1685 – 
1693, 2007. 
Stables CL, Glasser RL, Feldman EL.  Diabetic cardiac 
autonomic neuropathy: insights from animal models.  
Auton Neurosci: Basic Clin 177: 74-80, 2013. 
Yadav RL, Yadav PK, Yadav LK, Agrawal K, Sah SK, 
Islam MN.  Association between obesity and heart 
rate variability indices: in intuition toward cardiac 
autonomic alteration –a risk of CVD. Diab Met Synd 
Obes: Targets Therapy 10: 57- 64, 2017. 
Yokoi N, Hosino M, Hidaka S, Yoshida E, Beppu M, 
Hoshikawa R, Sudo K, Kawada A, Takagi S, Seino 
S. A novel rat model of type 2 diabetes: the Zucker 
fatty diametes mellitus ZFDM rat. J Diab Res , 2013. 
Ziraba AK1, Fotso JC, Ochako R. 
Overweight and obesity in urban Africa: 
A problem of the rich or the poor? BMC Public 
Health.  15;9:465, 2009. 
 
6
